Open Access

Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians

Sean Sileno

Sean Sileno

Mayo Clinic Department of Internal MedicineJacksonville,
Search for this author on
Sciendo|Google Scholar
Sileno, Sean
, 
Razvan M. Chirila

Razvan M. Chirila

Mayo Clinic Department of Internal MedicineJacksonville,
Search for this author on
Sciendo|Google Scholar
Chirila, Razvan M.
 and 
Dana M. Harris

Dana M. Harris

Mayo Clinic Department of Internal MedicineJacksonville,
Search for this author on
Sciendo|Google Scholar
Harris, Dana M.
  
Dec 17, 2020
Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: Dec 17, 2020
Page range: 181 - 187
Received: Jun 04, 2020
DOI: https://doi.org/10.2478/rjim-2020-0018
Keywords
© 2020 Sean Sileno et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Patients with chronic liver disease have associated comorbidities that require treatment, including cardiovascular disease, arrhythmias, cerebrovascular accidents and pain. These medications may affect the liver disease. Due to the complexity of medical problems in patients with chronic liver disease, treating clinicians benefit from targeted guidance for their care.

Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Internal Medicine, other, Cardiology, Gastroenterology, Rheumatology
Journal RSS Feed